[go: up one dir, main page]

HU0303948D0 - Solid orally-dispersible pharmaceutical formulation - Google Patents

Solid orally-dispersible pharmaceutical formulation

Info

Publication number
HU0303948D0
HU0303948D0 HU0303948A HUP0303948A HU0303948D0 HU 0303948 D0 HU0303948 D0 HU 0303948D0 HU 0303948 A HU0303948 A HU 0303948A HU P0303948 A HUP0303948 A HU P0303948A HU 0303948 D0 HU0303948 D0 HU 0303948D0
Authority
HU
Hungary
Prior art keywords
pharmaceutical formulation
solid orally
dispersible pharmaceutical
dispersible
orally
Prior art date
Application number
HU0303948A
Other languages
English (en)
Original Assignee
Roquette Freres
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Freres filed Critical Roquette Freres
Publication of HU0303948D0 publication Critical patent/HU0303948D0/hu
Publication of HUP0303948A2 publication Critical patent/HUP0303948A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0303948A 2002-01-18 2002-12-19 Szájban diszpergálódó szilárd gyógyszerforma HUP0303948A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0200647A FR2834889B1 (fr) 2002-01-18 2002-01-18 Forme pharmaceutique solide orodispersible
PCT/FR2002/004454 WO2003061623A1 (fr) 2002-01-18 2002-12-19 Forme pharmaceutique solide orodispersible

Publications (2)

Publication Number Publication Date
HU0303948D0 true HU0303948D0 (en) 2004-01-28
HUP0303948A2 HUP0303948A2 (hu) 2004-04-28

Family

ID=27589521

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303948A HUP0303948A2 (hu) 2002-01-18 2002-12-19 Szájban diszpergálódó szilárd gyógyszerforma

Country Status (22)

Country Link
US (1) US7201922B2 (hu)
EP (1) EP1465593B1 (hu)
JP (1) JP2005515240A (hu)
KR (1) KR100961367B1 (hu)
CN (1) CN1248681C (hu)
AT (1) ATE439828T1 (hu)
AU (1) AU2002364468C1 (hu)
BR (1) BR0208161A (hu)
CA (1) CA2441796A1 (hu)
CZ (1) CZ20032486A3 (hu)
DE (1) DE60233436D1 (hu)
FR (1) FR2834889B1 (hu)
HU (1) HUP0303948A2 (hu)
IL (2) IL158691A0 (hu)
MX (1) MXPA03008420A (hu)
NO (1) NO326259B1 (hu)
NZ (1) NZ529694A (hu)
PL (1) PL209144B1 (hu)
RU (1) RU2317812C2 (hu)
SK (1) SK287812B6 (hu)
WO (1) WO2003061623A1 (hu)
ZA (1) ZA200308664B (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
WO2000024380A1 (en) * 1998-10-27 2000-05-04 Fuisz Technologies Ltd. Microparticles containing peg and/or peg glyceryl esters
FR2834894B1 (fr) * 2002-01-21 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de piribedil
FR2834893B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de perindopril
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
FR2834896B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'ivabradine
DE10229472A1 (de) * 2002-07-01 2004-01-15 Symrise Gmbh & Co. Kg Kompaktierter Milchsäurementhylester
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
FR2858556B1 (fr) * 2003-08-06 2006-03-10 Galenix Innovations Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
TWI358407B (en) * 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
KR101109633B1 (ko) 2007-08-03 2012-01-31 제이더블유중외제약 주식회사 활성성분의 코팅막이 보호되는 구강내붕해제형을 제조하기위한 조성물
FR2920311B1 (fr) * 2007-08-31 2010-06-18 Galenix Innovations Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation
ES2758624T3 (es) * 2009-02-12 2020-05-06 Fuji Chem Ind Co Ltd Composición de partículas desintegrantes y material de desintegración rápida moldeado por compresión que comprende la misma
RU2497505C1 (ru) * 2012-11-07 2013-11-10 Максим Эдуардович Запольский Новая лекарственная композиция для лечения болевого синдрома при спазме гладкой мускулатуры
RU2503447C1 (ru) * 2012-11-20 2014-01-10 Максим Эдуардович Запольский Лекарственное средство в форме ородисперсной таблетки и способ получения лекарственного средства
US20160136091A1 (en) * 2013-07-19 2016-05-19 Sanwa Kagaku Kenkyusho Co., Ltd. Orally Disintegrating Tablet
DE102017103346A1 (de) * 2017-02-17 2018-08-23 Lts Lohmann Therapie-Systeme Ag Strukturierte orodispergierbare Filme
JP7138666B2 (ja) * 2018-01-24 2022-09-16 大原薬品工業株式会社 γ－アミノ酪酸誘導体含有錠剤の化学的安定性を改善する方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327077A (en) * 1981-05-29 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
JP3349535B2 (ja) * 1993-01-12 2002-11-25 フロイント産業株式会社 球形顆粒の製造方法
US5895664A (en) * 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
CN1222317C (zh) * 1996-07-12 2005-10-12 第一制药株式会社 可迅速崩解的压模物质及其生产方法
FR2752162B1 (fr) 1996-08-07 1998-11-06 Jouveinal Lab Comprime de maleate de trimebutine pellicule
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
WO2000057857A1 (en) 1999-03-25 2000-10-05 Yuhan Corporation Rapidly disintegrable tablet for oral administration
US6316029B1 (en) * 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
ATE371439T1 (de) * 2000-07-27 2007-09-15 Roquette Freres Granulat bestehend aus stärke und laktose
WO2002032403A1 (en) * 2000-10-16 2002-04-25 Daiichi Pharmaceutical Co., Ltd. Medicinal compositions quickly disintegrating in the oral cavity and process for producing the same
FR2823668B1 (fr) * 2001-04-20 2004-02-27 Ethypharm Lab Prod Ethiques Comprimes effervescents orodispersibles
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
US7118765B2 (en) * 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
PL371259A1 (en) * 2001-12-21 2005-06-13 Pfizer Products Inc. Directly compressible formulations of azithromycin
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
JP2005526095A (ja) * 2002-03-20 2005-09-02 エラン ファーマ インターナショナル，リミティド 脆砕性の低い急速溶解投与剤型

Also Published As

Publication number Publication date
ZA200308664B (en) 2004-11-08
PL362762A1 (en) 2004-11-02
NO20034139D0 (no) 2003-09-17
FR2834889B1 (fr) 2004-04-02
SK11712003A3 (sk) 2004-02-03
NO20034139L (no) 2003-11-11
EP1465593B1 (fr) 2009-08-19
HUP0303948A2 (hu) 2004-04-28
WO2003061623A1 (fr) 2003-07-31
US20030147947A1 (en) 2003-08-07
IL158691A0 (en) 2004-05-12
IL158691A (en) 2008-08-07
AU2002364468B2 (en) 2008-06-26
KR20040073288A (ko) 2004-08-19
MXPA03008420A (es) 2004-03-16
AU2002364468C1 (en) 2009-01-22
JP2005515240A (ja) 2005-05-26
NZ529694A (en) 2006-04-28
FR2834889A1 (fr) 2003-07-25
CN1516576A (zh) 2004-07-28
RU2003128025A (ru) 2005-03-27
PL209144B1 (pl) 2011-07-29
SK287812B6 (sk) 2011-10-04
RU2317812C2 (ru) 2008-02-27
EP1465593A1 (fr) 2004-10-13
CA2441796A1 (fr) 2003-07-31
KR100961367B1 (ko) 2010-06-07
BR0208161A (pt) 2004-03-02
CZ20032486A3 (cs) 2004-01-14
US7201922B2 (en) 2007-04-10
NO326259B1 (no) 2008-10-27
CN1248681C (zh) 2006-04-05
ATE439828T1 (de) 2009-09-15
DE60233436D1 (de) 2009-10-01

Similar Documents

Publication Publication Date Title
IL158691A0 (en) Solid orally-dispersible pharmaceutical formulation
TW200626526A (en) Pharmaceutical compositions for the treatment of neoplasms
IL174863A0 (en) Compounds that inhibit serine proteases and pharmaceutical compositions containing the same
IL175210A0 (en) Non-pancreatic proteases and pharmaceutical compositions containing the same
MXPA04008772A (es) Composiciones de clorhidrato de naltrexona.
DK1187613T3 (da) Amidsubstituerede imidazoquinoliner
IL171285A (en) Pharmaceuticals containing interleukin-6 antagonist and their uses
IL170454A (en) Preparations of active ingredients for administration through the skin or through mucous membranes and their uses
MY157827A (en) Sulfonamide substituted imidazoquinolines
HK1076742A1 (en) Orodispersible pharmaceutical composition comprising agomelatine
WO2003103571A3 (en) VACCINES AGAINST FLAVIVIRUSES
EP1419785A4 (en) MEDICAMENTS CONTAINING A CHYMASE INHIBITOR AND ACE INHIBITOR AS ACTIVE INGREDIENTS
IL164217A0 (en) Pharmaceutical compositions containing water-soluble propofol and methods of administering same
IL173929A0 (en) Analogues of kahalalide f and pharmaceutical compositions containing the same
IL169793A (en) Compounds containing antacids and antioxidants and using them for the preparation of a medicinal product
HUP0600778A3 (en) Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
IL173626A0 (en) Small peptides and oral pharmaceutical compositions containing the same
WO2005030142A8 (en) Rifalazil formulations
MY134019A (en) Aryl oxime-piperazines useful as ccr5 antagonists
TW200602062A (en) Improved formulations of 6-mercaptopurine
HK1076743A1 (en) Orodispersible pharmaceutical composition comprising perindopril
HK1094152A1 (en) Orodispersible pharmaceutical composition of an antithrombotic compound
AU2003291757A8 (en) Formulations of low solubility bioactive agents and processes for making the same
WO2006044548A3 (en) Clopidogrel compositions
GB0201607D0 (en) Formulation for the administration of medicinal substances